696628-79-2 Usage
Chemical structure
A complex structure that includes a 1,2,5-oxadiazol-3-yl group, a fluorophenyl group, and a 1,2,3-triazole-4-carboxylic acid moiety.
Pharmaceutical
Due to its unique structure, it may have biological activity and could be used in the development of new drugs.
Industrial
Its structure may also impart specific properties such as fluorescence or catalytic activity, making it useful in various industrial processes.
Research and investigation
Further research and investigation into the properties and applications of 1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-(fluorophenyl)-1H-1,2,3-triazole-4-carboxylic may provide valuable insights into its potential uses and effects.
Biological activity
The presence of the 4-amino-1,2,5-oxadiazol-3-yl group may contribute to the compound's potential biological activity, making it a candidate for further study in the development of pharmaceuticals.
Fluorescence
The fluorophenyl group may impart fluorescence properties to the compound, which could be useful in various applications such as imaging or sensing.
Catalytic activity
The unique structure of the compound, including the 1,2,3-triazole-4-carboxylic acid moiety, may provide catalytic activity, making it a candidate for use in chemical reactions or processes.
Further study
Due to its complex structure and potential applications, further study of 1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-(fluorophenyl)-1H-1,2,3-triazole-4-carboxylic is necessary to fully understand its properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 696628-79-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,6,6,2 and 8 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 696628-79:
(8*6)+(7*9)+(6*6)+(5*6)+(4*2)+(3*8)+(2*7)+(1*9)=232
232 % 10 = 2
So 696628-79-2 is a valid CAS Registry Number.
696628-79-2Relevant academic research and scientific papers
Kulikov,Epishina,Batog,Rozhkov,Makhova,Konyushkin,Semenova,Semenov
, p. 836 - 843 (2013)
A method of 3-amino-4-[5-aryl(heteroaryl)-1H-1,2,3-triazol-1-yl)]furazan synthesis was optimized. Condensation of these compounds with 2,5-dimethoxytetrahydrofuran resulted in a series of previously unknown 4-[5-aryl(heteroaryl)-1H-1,2,3-triazol-1-yl)]-3-(pyrrol-1-yl)furazans. All target compounds were evaluated for both antimitotic microtubule destabilizing effect in a phenotypic sea urchin embryo assay and cytotoxicity in a panel of 60 human cancer cell lines. Pyrrolyl derivatives of triazolylfurazans were determined as antiproliferative compounds. The most potent microtubule targeting compounds 7a and 7e are of interest for further trials as antineoplastic agents.
